quinuclidines has been researched along with Dyspepsia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wilkes, G | 1 |
| Armstrong, I; Biel, MA; Chambers, MS; Chen, Y; Garden, AS; Haddad, R; Hodge, KM; Holland, JM; Jones, CU; Ship, JA; Vitti, R; Weber, RS | 1 |
| Chiba, T; Inomata, M; Kudara, N; Orii, S; Sato, M; Suzuki, K | 1 |
| Fischer, AR | 1 |
4 other study(ies) available for quinuclidines and Dyspepsia
| Article | Year |
|---|---|
Antiemetic agents.
Topics: Administration, Oral; Anorexia; Antiemetics; Antineoplastic Agents; Aprepitant; Asthenia; Constipation; Diarrhea; Drug Interactions; Dyspepsia; Fatigue; Fever; Granisetron; Headache; Hiccup; Humans; Indoles; Injections, Intravenous; Isoquinolines; Morpholines; Nausea; Neoplasms; Ondansetron; Palonosetron; Quinolizines; Quinuclidines; Vomiting | 2007 |
Open-label, long-term safety study of cevimeline in the treatment of postirradiation xerostomia.
Topics: Adult; Aged; Aged, 80 and over; Diarrhea; Dyspepsia; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Muscarinic Agonists; Nausea; Quinuclidines; Radiotherapy Dosage; Sweat; Thiophenes; Xerostomia | 2007 |
Effect of a muscarinic M3 receptor agonist on gastric motility.
Topics: Administration, Oral; Adult; Aged, 80 and over; Drug Administration Schedule; Dyspepsia; Female; Gastrointestinal Agents; Gastrointestinal Motility; Humans; Muscarinic Agonists; Proton Pump Inhibitors; Quinuclidines; Receptor, Muscarinic M3; Thiophenes; Treatment Outcome | 2007 |
[On the therapy of cholecystopathy and dyspepsia with librax].
Topics: Adult; Aged; Benzilates; Chlordiazepoxide; Dyspepsia; Female; Gallbladder Diseases; Humans; Male; Middle Aged; Parasympatholytics; Quaternary Ammonium Compounds; Quinuclidines | 1968 |